|
GBF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.476400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.466400E-01 |
| Normal-vs-Stage2 |
8.455400E-01 |
| Normal-vs-Stage3 |
9.258600E-01 |
| Normal-vs-Stage4 |
9.759000E-01 |
| Stage1-vs-Stage2 |
8.971800E-01 |
| Stage1-vs-Stage3 |
5.411800E-01 |
| Stage1-vs-Stage4 |
6.761000E-01 |
| Stage2-vs-Stage3 |
7.717600E-01 |
| Stage2-vs-Stage4 |
8.654600E-01 |
| Stage3-vs-Stage4 |
9.036600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.647200E-01 |
| Normal-vs-AfricanAmerican |
2.162200E-02 |
| Normal-vs-Asian |
3.176600E-01 |
| Caucasian-vs-AfricanAmerican |
3.681800E-02 |
| Caucasian-vs-Asian |
3.651800E-01 |
| AfricanAmerican-vs-Asian |
2.434800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.711600E-01 |
| Normal-vs-Female |
5.791600E-01 |
| Male-vs-Female |
2.905200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.261400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.922000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.739400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.800800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.027600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.841400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.985400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.442800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.263400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.758200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.705600E-01 |
| Classical-VS-Follicular |
1.036610E-04 |
| Classical-VS-Other |
4.683700E-02 |
| Classical-VS-Normal |
1.773400E-01 |
| Tall-VS-Follicular |
3.041400E-01 |
| Tall-VS-Other |
1.829250E-01 |
| Tall-VS-Normal |
7.758200E-01 |
| Follicular-VS-Other |
5.676400E-01 |
| Follicular-VS-Normal |
9.130400E-02 |
| Other-VS-Normal |
1.064830E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.794200E-01 |
| Normal-vs-N1 |
5.155400E-01 |
| N0-vs-N1 |
4.595400E-01 |
|
|
